Stock listing

NASDAQ:TCGX TCGX Acquisition Corp. Stock

Follow TCGX Acquisition Corp. into a list and get an email when it puts out news.

Share price · NASDAQ:TCGX

$10.02 USD 0.00 (0.0%)

Close on Nov 20, 2026

Past 3 months +0.2% · daily closes, Aug 4, 2026 – Nov 20, 2026, adjusted for splits
Day range
$10.00 – $10.03 USDNov 20, 2026
Volume
123,234 sharesNov 20, 2026
Market cap
$91.66M USDAt the close on Nov 20, 2026 · price × 9.15M shares outstanding
Traded on an average day
$1.19M USDMedian day 22,800 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:TCGX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$10.020.000.0%$10.00$10.03$10.00123,234
$10.02-0.01-0.1%$10.02$10.04$10.0213,935
$10.03+0.03+0.3%$10.02$10.03$10.0249,520
$10.00-0.01-0.1%$10.02$10.02$10.0018,739
$10.01-0.015-0.1%$10.01$10.02$10.011,150
$10.03-0.015-0.1%$10.06$10.06$10.019,491
$10.040.000.0%$10.04$10.04$10.0410,529
$10.04-0.01-0.1%$10.05$10.06$10.018,956
$10.05+0.01+0.1%$10.05$10.05$10.019,608
$10.04+0.01+0.1%$10.03$10.04$10.031,426
$10.03-0.01-0.1%$10.03$10.03$10.01122,800
$10.04+0.01+0.1%$10.05$10.05$10.0254,114
$10.030.000.0%$10.03$10.05$10.0313,961
$10.03-0.0050.0%$10.03$10.08$10.0218,839
$10.04-0.025-0.2%$10.06$10.08$10.0247,669
$10.06-0.025-0.2%$10.10$10.10$10.05132,292
$10.09-0.015-0.1%$10.12$10.12$10.0735,398
$10.10-0.04-0.4%$10.15$10.16$10.05423,428
$10.14+0.04+0.4%$10.11$10.14$10.1088,249
$10.10+0.07+0.7%$10.02$10.15$10.02178,600
$10.03+0.03+0.3%$10.02$10.06$10.00296,700
$10.00-0.01-0.1%$10.02$10.08$9.99643,100
$10.01-0.01-0.1%$10.03$10.11$10.001,084,500
$10.02-2.28-18.5%$12.10$12.27$9.901,796,200
$12.30-0.06-0.5%$12.80$12.80$12.30500
$12.36-0.52-4.0%$12.36$12.36$12.36200
$12.88+0.52+4.2%$12.47$13.30$12.4318,700
$12.36+0.04+0.3%$12.21$16.99$12.0924,500
$12.32-0.19-1.5%$12.32$12.32$12.321,100
$12.51+0.48+4.0%$12.24$12.59$12.24900
$12.03-0.56-4.4%$12.35$12.35$12.031,100
$12.59-0.16-1.3%$12.58$12.59$12.58300
$12.750.000.0%$12.75$12.75$12.750
$12.750.000.0%$12.75$12.75$12.750
$12.75+0.50+4.1%$12.75$12.75$12.752,000
$12.25-0.26-2.1%$12.91$12.91$11.7728,900
$12.51-0.86-6.4%$13.47$13.50$12.507,400
$13.37-0.28-2.1%$13.74$13.88$13.377,200
$13.65-0.45-3.2%$13.80$13.92$13.459,000
$14.10-0.28-1.9%$14.45$14.46$14.105,400
$14.38-0.35-2.4%$14.47$14.85$13.7114,700
$14.73+0.18+1.2%$14.00$15.40$14.0017,800
$14.55+0.24+1.7%$14.70$15.28$13.9036,600
$14.31-0.34-2.3%$14.40$15.25$13.8122,800
$14.65-0.38-2.5%$14.85$15.00$14.655,900
$15.03+1.18+8.5%$14.00$16.00$13.8354,600
$13.85+0.55+4.1%$13.50$14.21$13.1320,200
$13.30+0.29+2.2%$13.25$13.30$13.195,500
$13.01-0.43-3.2%$14.22$14.22$13.0023,900
$13.44-0.27-2.0%$13.65$14.00$12.4828,800
$13.71-0.04-0.3%$13.75$13.94$13.4842,500
$13.75-0.26-1.9%$13.83$14.10$13.5355,100
$14.01-0.04-0.3%$14.05$14.26$13.6512,200
$14.05-0.14-1.0%$14.01$14.35$13.6317,100
$14.19-0.03-0.2%$14.04$14.70$14.0241,600
$14.22+0.27+1.9%$14.15$14.51$13.75168,800
$13.95-0.15-1.1%$13.97$14.10$13.5753,500
$14.10+0.43+3.1%$13.83$14.40$13.2938,500
$13.67-0.11-0.8%$13.69$14.90$13.26325,500
$13.78-0.13-0.9%$13.83$14.00$13.2673,300
$13.91+0.02+0.1%$13.88$14.08$13.5899,200
$13.89-0.11-0.8%$14.01$14.75$13.2126,800
$14.00+0.10+0.7%$13.24$14.04$13.2420,700
$13.90-0.20-1.4%$13.00$15.05$13.00137,000
$14.10-0.79-5.3%$15.24$16.25$13.22395,500
Ticker
NASDAQ:TCGX
Asset type
Stock
Sector
Financials
Industry
Shell companies & SPACs
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All TCGX Acquisition Corp. news

TCGX Acquisition Corp. on 6ix

Sector
Financials
Industry
Shell companies & SPACs
News releases
5 in the last 12 months · 5 in all · newest Nov 9, 2026 · oldest 2026
Decks
1 deck · latest Oct 19, 2026

Valuation

balance Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$91.66M USD
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta vs S&P 500
Under 6 months of closes

Shell companies & SPACs: the 10 companies nearest in size, of 284 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
TCGX Acquisition Corp. · NASDAQ:TCGXUS$91.66MUS$91.66Mn/an/an/an/an/an/an/a
Future Vision II Acquisition Corporation · NASDAQ:FVNUS$101.5MUS$100.7M58.6×n/an/an/an/an/a0.02
Charlton Aria Acquisition Corporation · NASDAQ:CHARUS$97.20MUS$97.16M46.9×n/an/an/an/an/a0.02
Tavia Acquisition Corp. · NASDAQ:TAVIUS$94.80MUS$94.69M73.1×n/an/an/an/an/a0.02
Research Alliance Corporation IV · NASDAQ:RACDUS$93.90MUS$93.90Mn/an/an/an/an/an/an/a
Miluna Acquisition Corp · NASDAQ:MMTXUS$90.80MUS$90.70Mn/an/an/an/an/an/a0.01
ChampionsGate Acquisition Corporation · NASDAQ:CHPGUS$90.74MUS$90.72M39.6×n/an/an/an/an/a0.00
Origin Investment Corp I · NASDAQ:ORIQUS$90.13MUS$89.79M56.9×n/an/a288×n/a0.0×0.00
Archimedes Tech SPAC Partners II Co. · NASDAQ:ATIIUS$89.95MUS$89.54Mn/an/an/an/an/an/a0.51
Peace Acquisition Corp · NASDAQ:PECEUS$84.97MUS$84.70Mn/an/an/a505×n/a0.0×n/a
JATT II Acquisition Corp · NASDAQ:JATTUS$81.82MUS$80.82Mn/an/an/an/an/an/a0.13
Median of the othersUS$90.77MUS$90.71M56.9×396×0.0×0.02

Decks

DeckKindSlidesDate
SPAC Merger (October 2026)SPAC merger31 slidesOct 19, 2026

Open Decks

Financings

RaiseDate
Private placement of common stock (PIPE)
Announced: US$160M · US$10 a share · Jefferies +3
Dealers: Jefferies (co-lead), TD Cowen (co-lead), Cantor, LifeSci Capital
Buyers: TCGX; Viking Global Investors; ADAR1 Capital Management; BVF Partners; Samsara BioCapital; Vianti Capital
Use of proceeds: Complete Phase 3 trials of elismetrep and submit an NDA, run a migraine prevention trial, and prepare for a potential U.S. launch
Oct 19, 2026
Public offering of class A ordinary shares
Closed: US$10 a share · Jefferies
Dealers: Jefferies (lead)
Aug 6, 2026

Open Financings · Read by 6ix AI from the company's releases

IPO

A blank check company (SPAC). Priced at US$10.00 a share on Aug 4, 2026.

Price
US$10.00 a share
Shares offered
7,500,000 Class A ordinary shares
Offering size
US$75 million
Underwriters' option
Up to 1,125,000 more shares
Listing
TCGX on the Nasdaq Capital Market
Underwriter
Jefferies
Shares delivered
On or about Aug 6, 2026

Steps

StepWhen
Draft sent to the SEC in confidenceJun 23, 2026
Filed publiclyJul 20, 2026
Amended onceJul 31, 2026
Shares registered with an exchangeAug 4, 2026
Declared effective by the SECAug 4, 2026
Final prospectus, with the priceAug 6, 2026

Open IPO · From the cover of the final prospectus (424B4) filed Aug 6, 2026

Filings

FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 9, 2026Quarterly reportSEC
425Nov 9, 2026Other filingsSEC
425Nov 2, 2026Other filingsSEC
425Oct 19, 2026Other filingsSEC
425Oct 19, 2026Other filingsSEC
425Oct 19, 2026Other filingsSEC
8-K · Current reportOct 19, 2026Material contractSEC
All 29 filings
FilingDateTypeFiled with
10-Q · Quarterly reportSep 10, 2026Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeAug 13, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 12, 2026Big-stake noticeSEC
8-K · Current reportAug 12, 2026Current reportSEC
4 · Change in ownershipAug 6, 2026Insider tradeSEC
3/A · Initial statement of ownership, amendedAug 6, 2026Insider tradeSEC
8-K · Current reportAug 6, 2026Material contractSEC
424B4 · ProspectusAug 5, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveAug 5, 2026Other filingsSEC
3 · Initial statement of ownershipAug 4, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 4, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 4, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 4, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 4, 2026Insider tradeSEC
CERT · Exchange's certificate of listingAug 4, 2026Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeAug 4, 2026Other filingsSEC
S-1/A · Registration statement, amendedJul 31, 2026Offer documentSEC
S-1 · Registration statementJul 20, 2026Offer documentSEC
DRS · Draft registration statementJun 23, 2026Offer documentSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from TCGX Acquisition Corp.’s releases · as of Oct 19, 2026

Common shares
9,147,500
Fully diluted
9,147,500

Fully diluted

LineSharesAs of
Common shares9,147,500Aug 6, 2026

Share count over time

CountShares
Aug 6, 20269,147,500

Open Cap table

Shareholders

Institutions

HolderSharesValueChange vs Jun 30Filed
ADAR1 Capital Management, LLC500KUS$6.26MNewNov 16, 2026
Ra Capital Management, L.P.500KUS$6.25MNewNov 16, 2026
Janus Henderson500KUS$6.44MFirst reportNov 16, 2026
Bvf Inc500KUS$6.25MNewNov 16, 2026
Nantahala Capital Management, LLC413KUS$5.17MNewNov 13, 2026
Squadron Capital Management LLC370KUS$4.63MNewNov 16, 2026
Woodline Partners LP300KUS$3.76MNewNov 16, 2026
Eventide Asset Management, LLC300KUS$3.75MNewNov 13, 2026
Commodore Capital LP300KUS$3.75MNewNov 16, 2026
Frazier Life Sciences Management, L.P.300KUS$3.75MNewNov 16, 2026
All 37 holders
HolderSharesValueChange vs Jun 30Filed
Paradigm Biocapital Advisors LP300KUS$3.75MNewNov 16, 2026
Adage Capital Partners Gp, L.L.C.300KUS$3.75MNewNov 16, 2026
Deep Track Capital, LP300KUS$3.75MNewNov 16, 2026
Spruce Street Capital LP300KUS$3.75MNewNov 13, 2026
Venrock Adviser, LLC300KUS$3.75MNewNov 16, 2026
Redmile Group, LLC300KUS$3.75MNewNov 16, 2026
Trails Edge Capital Partners, LP250KUS$3.13MNewNov 16, 2026
Balyasny Asset Management L.P.250KUS$3.13MNewNov 16, 2026
EcoR1 Capital, LLC250KUS$3.13MNewNov 16, 2026
Soleus Capital Management, L.P.225KUS$2.81MNewNov 16, 2026
Nan Fung Group Holdings Ltd200KUS$2.5MNewNov 13, 2026
Logos Global Management LP200KUS$2.5MNewNov 19, 2026
Caligan Partners LP200KUS$2.5MNewNov 16, 2026
Affinity Asset Advisors, LLC200KUS$2.5MNewNov 13, 2026
Samsara Biocapital, LLC100KUS$1.25MNewNov 16, 2026
Stempoint Capital LP100KUS$1.25MNewNov 16, 2026
Seven Fleet Capital Management LP100KUS$1.25MNewNov 16, 2026
Moore Capital Management, LP75,744US$948KNewNov 16, 2026
Ameriprise51,800US$648KNewNov 16, 2026
Ikarian Capital, LLC50,000US$626KNewNov 16, 2026
Boothbay Fund Management, LLC46,640US$583KNewNov 16, 2026
Geode Capital42,604US$533KNewNov 6, 2026
Abc Arbitrage SA19,399US$243KNewOct 23, 2026
UBS3,596US$44,986NewNov 10, 2026
Clear Street Group Inc.2,500US$31,275NewNov 16, 2026
Persistent Asset Partners Ltd2,121US$26,534NewNov 12, 2026
BNP Paribas1,871US$23,406NewNov 12, 2026

Big stakes

HolderStakeSharesDate
TCGX Sponsor, LLC22.30%2.5MSep 30, 2026
Sirenia Capital Management LP5.50%500KSep 30, 2026
ADAR1 Capital Management, LLC5.50%500KSep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Daniel Lynch
Other companies: SpringWorks Therapeutics Inc (Director · Since at least Sep 12, 2019); Xilio Therapeutics, Inc. (Director · Oct 21, 2021 – Oct 21, 2021 · Past); 2Seventy Bio Inc (Director · Oct 18, 2021 – Jun 13, 2023 · Past); Omega Alpha SPAC (Director · Jan 6, 2021 – Jan 6, 2021 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Dec 31, 2020 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – Jun 19, 2019 · Past); Surface Oncology Inc (Director · Apr 18, 2018 – Jun 10, 2020 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 24, 2020 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – May 19, 2017 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 9, 2015 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Nov 11, 2021 · Past)
Chairman of the TriGemX Bio Board of Directors · Since Nov 9, 2026
Andrew Cheng
Other companies: Damora Therapeutics, Inc. (Board Director · Since at least Aug 10, 2026); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); Akero Therapeutics Inc (President and CEO, Director · Since at least Jun 19, 2019); Arbutus Biopharma Corporation (Director · Aug 17, 2019 – Jun 3, 2021 · Past)
Director · Since at least Aug 4, 2026
Lin Wei
Other companies: Revolution Medicines, Inc. (Chief Medical Officer · Since at least Mar 21, 2024); 2Seventy Bio Inc (Director · Mar 7, 2023 – May 13, 2025 · Past); Erasca, Inc. (Chief Medical Officer · Jul 15, 2021 – Feb 1, 2023 · Past)
Director · Since at least Aug 4, 2026
Chen-Ming Yu
Other companies: TCGX Acquisition Corp. II (Chief Executive Officer, Director · Since at least Oct 19, 2026); Sagent Pharmaceuticals Inc (Interim COO · Apr 19, 2011 – Sep 7, 2012 · Past)
Chief Executive Officer · Since at least Aug 4, 2026
Ying Huang
Other companies: ADARx Pharmaceuticals, Inc. (Board Member · Since at least Sep 24, 2026); Legend Biotech Corp. (Chief Executive Officer, Director · Since at least Mar 18, 2026)
Director · Since at least Aug 4, 2026
Craig David SkalingChief Financial Officer · Since at least Aug 4, 2026

Open People

Log in to ask 6ix AI your own questions about TCGX Acquisition Corp.